Research Paper Volume 11, Issue 23 pp 11010—11029
Reactive oxygen species metabolism-based prediction model and drug for patients with recurrent glioblastoma
Figure 3. The relationship between recurrence score and gene mutation, aneuploidy scores, and tumor purity of GBM. (A–C) The gene mutation counts showed no significant difference in different recurrence risk groups. NSp>0.05. (D–F) The aneuploidy score showed no significant difference in different recurrence risk groups. NSp>0.05. (G–I) High recurrence risk group with lower tumor purity, higher stroma proportion and higher leukocyte proportion. ****p<0.0001.